The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Top Cited Papers
- 13 March 2001
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (6), 3369-3374
- https://doi.org/10.1073/pnas.051551698
Abstract
The pregnane X receptor (PXR) is the molecular target for catatoxic steroids such as pregnenolone 16α-carbonitrile (PCN), which induce cytochrome P450 3A (CYP3A) expression and protect the body from harmful chemicals. In this study, we demonstrate that PXR is activated by the toxic bile acid lithocholic acid (LCA) and its 3-keto metabolite. Furthermore, we show that PXR regulates the expression of genes involved in the biosynthesis, transport, and metabolism of bile acids including cholesterol 7α-hydroxylase (Cyp7a1) and the Na+-independent organic anion transporter 2 (Oatp2). Finally, we demonstrate that activation of PXR protects against severe liver damage induced by LCA. Based on these data, we propose that PXR serves as a physiological sensor of LCA, and coordinately regulates gene expression to reduce the concentrations of this toxic bile acid. These findings suggest that PXR agonists may prove useful in the treatment of human cholestatic liver disease.Keywords
This publication has 42 references indexed in Scilit:
- Humanized xenobiotic response in mice expressing nuclear receptor SXRNature, 2000
- 6α-Hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- Hepatic levels of bile acids in end-stage chronic cholestatic liver diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1996
- Stimulation of bile acid 6α-hydroxylation by rifampinJournal of Hepatology, 1996
- Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.Proceedings of the National Academy of Sciences, 1993
- Pruritus and cholestasis: Therapeutic optionsJournal of Gastroenterology and Hepatology, 1993
- COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSISThe Lancet, 1989
- Hormones and ResistanceJournal of Pharmaceutical Sciences, 1971
- Cholestasis in Rats induced by TaurolithocholateNature, 1966